Jason Robertson
Gründer bei Nimbus Synergies, Inc.
Profil
Jason Robertson is the founder of Nimbus Synergies, Inc. (founded in 2017) where he holds the title of Managing Partner.
He is currently the Director at Blue Mesa Health, Inc. and a Board Member at LifeBooster, Inc. (since 2020).
Additionally, he is the Principal at Epifini Consulting (since 2000).
In his former positions, Mr. Robertson served as the Chairman at Alavida Health Ltd., Director at Aquinox Pharmaceuticals, Inc. (from 2013 to 2016), Chief Technology Officer at LifePilot (from 2006 to 2007), and Board Member at Alavida Health Ltd.
(in 2021).
Mr. Robertson completed his undergraduate degree at McGill University in 2003 and obtained an MBA from the University of British Columbia in 2010.
Aktive Positionen von Jason Robertson
| Unternehmen | Position | Beginn |
|---|---|---|
Blue Mesa Health, Inc.
 Blue Mesa Health, Inc. BiotechnologyHealth Technology Blue Mesa Health, Inc. engages in the provision of digital therapeutics program to support the prevention diabetes and other chronic diseases. The company was founded by Misa Nuccio, Curtis Duggan, Evan Willms, Mike Benna, Jonathan Bixby, and Joshua Bixby in 2015 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Nimbus Synergies, Inc.
 Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | Gründer | 01.05.2017 |
LifeBooster, Inc.
 LifeBooster, Inc. Miscellaneous Commercial ServicesCommercial Services LifeBooster, Inc. operates an open-innovation platform technology company operating at the intersection of data analytics, industrial IoT and Insurtech. The company was founded by Bryan Statham, Stacey Wallin and Lawrence Chee and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 01.06.2020 |
| Epifini Consulting | Corporate Officer/Principal | 01.01.2000 |
Ehemalige bekannte Positionen von Jason Robertson
| Unternehmen | Position | Ende |
|---|---|---|
Alavida Health Ltd.
 Alavida Health Ltd. Medical/Nursing ServicesHealth Services Alavida Health Ltd. provides treatment for alcohol use disorder. The company was founded by Elliot Stone, Diane Rothon and Terri-Lynn MacKay and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 30.10.2021 |
Alavida Health Ltd.
Alavida Health Ltd. Medical/Nursing ServicesHealth Services Alavida Health Ltd. provides treatment for alcohol use disorder. The company was founded by Elliot Stone, Diane Rothon and Terri-Lynn MacKay and is headquartered in Vancouver, Canada. | Vorsitzender | 04.05.2021 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 30.03.2016 |
| LifePilot | Technik-/Wissenschafts-/F&E-Leiter | 30.03.2007 |
Ausbildung von Jason Robertson
| McGill University | Undergraduate Degree |
| University of British Columbia | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| LifePilot | |
Blue Mesa Health, Inc.
Blue Mesa Health, Inc. BiotechnologyHealth Technology Blue Mesa Health, Inc. engages in the provision of digital therapeutics program to support the prevention diabetes and other chronic diseases. The company was founded by Misa Nuccio, Curtis Duggan, Evan Willms, Mike Benna, Jonathan Bixby, and Joshua Bixby in 2015 and is headquartered in New York, NY. | Health Technology |
Alavida Health Ltd.
Alavida Health Ltd. Medical/Nursing ServicesHealth Services Alavida Health Ltd. provides treatment for alcohol use disorder. The company was founded by Elliot Stone, Diane Rothon and Terri-Lynn MacKay and is headquartered in Vancouver, Canada. | Health Services |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | Finance |
LifeBooster, Inc.
LifeBooster, Inc. Miscellaneous Commercial ServicesCommercial Services LifeBooster, Inc. operates an open-innovation platform technology company operating at the intersection of data analytics, industrial IoT and Insurtech. The company was founded by Bryan Statham, Stacey Wallin and Lawrence Chee and is headquartered in Vancouver, Canada. | Commercial Services |
| Epifini Consulting |
